| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive VP &President, Mrl | Director
2 companies
Li Dean Y is a Director at RECURSION PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $14.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2024 | MRK Merck & Co., Inc. | Executive VP &President, Mrl | Sale+OE | 14,702 | $125.50 | $1,845,083.36 | -24.1% | +4.5% | -28.5% | |
| Jan 9, 2024 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 29,000 | $13.66 | $396,213.83 | -3.3% | -32.8% | -45.8% | |
| Dec 7, 2021 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 15,900 | $20.48 | $325,630.39 | -0.6% | -65.8% | -55.0% | |
| Nov 19, 2021 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 19,100 | $20.16 | $384,962.04 | -1.6% | -46.3% | -50.4% |